Athira Pharma, Inc.

NASDAQ:ATHA

0.8 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -117.672-95.639-54.853-19.955-5.161-5.097
Depreciation & Amortization 0.9690.8450.4790.25100
Deferred Income Tax -0.01200-0.251-00
Stock Based Compensation 10.62310.6064.6230.6330.2530.196
Change In Working Capital 6.52711.9386.16-6.4450.6780.245
Accounts Receivables -0.4011.109-1.036-0.001-00
Inventory 0-1.1091.0360.00100
Accounts Payables 7.3672.1015.152.6010.7010.291
Other Working Capital -0.4399.8371.01-9.046-0.0230.245
Other Non Cash Items -1.188-0.2190.4931.6540.5170.173
Operating Cash Flow -100.753-72.469-43.098-24.113-3.713-4.483
Investing Activities:
Investments In Property Plant And Equipment -0.304-1.141-1.573-2.3200
Acquisitions Net -95.393-0.0590.003000
Purchases Of Investments -27.671-95.288-299.197-226.837-0.995-5.25
Sales Maturities Of Investments 123.064154.093296.69119.0532.4957.25
Other Investing Activites 95.3930.059-0.0030.0360.0060.007
Investing Cash Flow 95.08957.664-4.079-210.0681.5062.007
Financing Activities:
Debt Repayment 000000
Common Stock Issued 0.4930.65496.762208.5170.0720.112
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 00.0010.32785.8971.7481.464
Financing Cash Flow 0.4930.65497.089292.750.9461.464
Other Information:
Effect Of Forex Changes On Cash 5.16600000
Net Change In Cash -5.382-14.15149.91258.569-1.261-1.012
Cash At End Of Period 90.58496.386110.53760.6252.0563.317